{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:41:27Z","timestamp":1791322887049,"version":"4.3.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.vaccine.2004.11.061","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T13:27:00Z","timestamp":1103722020000},"page":"2825-2840","source":"Crossref","is-referenced-by-count":133,"title":["Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes"],"prefix":"10.1016","volume":"23","author":[{"given":"Jean-Loup","family":"Lemesre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Holzmuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Cavaleyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Bras","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Hottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Papierok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.11.061_bib1","unstructured":"Lemesre JL. Methods for the culture in vitro of different stages of tissue parasites, International publication WO 94\/26899, 1994."},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4269\/ajtmh.1999.60.41","article-title":"Leishmania spp: completely defined medium without serum and macromolecules (CDM\/LP) for the continuous in vitro cultivation of infective promastigote forms","volume":"60","author":"Merlen","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.061_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/00034983.1986.11812021","article-title":"Leishmaniasis in Sardinia. I. Observations on a larval breeding site of Phlebotomus perniciosus, Phlebotomus perfiliewi perfiliewi and Sergentomyia minuta (Diptera: Psychodidae) in the canine leishmaniasis focus of Soleminis (Cagliari)","volume":"80","author":"Bettini","year":"1986","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.1993.48.1","article-title":"Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test\u2013enzyme-linked immunosorbent assay (FAST\u2013ELISA) for field diagnosis of canine visceral leishmaniasis","volume":"48","author":"Ashford","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4269\/ajtmh.1996.55.39","article-title":"A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi","volume":"55","author":"Paranhos-Silva","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.061_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2004.11.061_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/00034983.1988.11812290","article-title":"Epidemiological studies on American leishmaniasis in Ceara State, Brazil. Molecular characterization of the Leishmania isolates","volume":"82","author":"Vasconcelos","year":"1988","journal-title":"Ann Trop Med Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.061_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0035-9203(88)90511-1","article-title":"Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy","volume":"82","author":"Gradoni","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2004.11.061_bib9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4269\/ajtmh.2001.65.510","article-title":"Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil","volume":"65","author":"Palatnik-de-Sousa","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2004.11.061_bib10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/516096","article-title":"Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil","volume":"25","author":"Dietze","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4269\/ajtmh.1998.59.53","article-title":"Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil","volume":"59","author":"Ashford","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2004.11.061_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","article-title":"Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment","volume":"86","author":"Gramiccia","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.061_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0952-7915(06)80032-4","article-title":"Immunology of leishmaniasis","volume":"4","author":"Locksley","year":"1992","journal-title":"Curr Opin Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2004.11.061_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-4017(00)00223-5","article-title":"The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection","volume":"90","author":"Solano-Gallego","year":"2000","journal-title":"Vet Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0020-7519(97)00169-0","article-title":"The immune response to Leishmania: mechanisms of parasite control and evasion","volume":"28","author":"Bogdan","year":"1998","journal-title":"Int J Parasitol"},{"issue":"9","key":"10.1016\/j.vaccine.2004.11.061_bib16","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.4049\/jimmunol.147.9.3149","article-title":"IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis","volume":"147","author":"Scott","year":"1991","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0923-2494(91)90007-6","article-title":"Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection","volume":"142","author":"Locksley","year":"1991","journal-title":"Res Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.061_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.181.3.961","article-title":"Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response","volume":"181","author":"Swihart","year":"1995","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.061_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0952-7915(98)80121-0","article-title":"Regulation of protective immunity against Leishmania major in mice","volume":"10","author":"Louis","year":"1998","journal-title":"Curr Opin Immunol"},{"issue":"5100","key":"10.1016\/j.vaccine.2004.11.061_bib20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.8451641","article-title":"TH1 and TH2 cell antigen receptors in experimental leishmaniasis","volume":"259","author":"Reiner","year":"1993","journal-title":"Science"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2004.11.061_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0165-2427(96)05755-8","article-title":"Epidermal immunocompetence in canine leishmaniasis","volume":"56","author":"Fondevila","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/IAI.67.1.237-243.1999","article-title":"Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production","volume":"67","author":"Pinelli","year":"1999","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2004.11.061_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-2427(99)00073-2","article-title":"Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum","volume":"70","author":"De Luna","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2004.11.061_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(99)00096-3","article-title":"The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy","volume":"71","author":"Moreno","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.061_bib26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1939-1676.1999.tb02190.x","article-title":"Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum","volume":"13","author":"Cavaliero","year":"1999","journal-title":"J Vet Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-2427(99)00088-4","article-title":"Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment","volume":"71","author":"Rhalem","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.061_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-3024.1989.tb00676.x","article-title":"Vaccination trial against canine visceral leishmaniasis. Phocean Veterinary Study Group on Visceral Leishmaniasis","volume":"11","author":"Dunan","year":"1989","journal-title":"Parasite Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.11.061_bib29","first-page":"441","article-title":"Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes","volume":"30","author":"Lasri","year":"1999","journal-title":"Vet Res"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2004.11.061_bib30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0264-410X(98)00338-7","article-title":"Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis","volume":"17","author":"De Luca","year":"1999","journal-title":"Vaccine"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2004.11.061_bib31","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"issue":"259","key":"10.1016\/j.vaccine.2004.11.061_bib32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2004.11.061_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0022-1759(91)90377-R","article-title":"Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporation. An easy and low cost alternative to radioactive thymidine incorporation","volume":"140","author":"Huong","year":"1991","journal-title":"J Immunol Methods"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2004.11.061_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S0031182000072243","article-title":"Experiences with vaccines against cutaneous leishmaniasis: of men and mice","volume":"98","author":"Modabber","year":"1989","journal-title":"Parasitology"},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.061_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00034983.1994.11812879","article-title":"Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy","volume":"88","author":"Alvar","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"10.1016\/j.vaccine.2004.11.061_bib36","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/eji.1830250619","article-title":"Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner","volume":"25","author":"Pinelli","year":"1995","journal-title":"Eur J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2004.11.061_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2427(97)00072-X","article-title":"Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs","volume":"59","author":"Bourdoiseau","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2004.11.061_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00034983.1995.11813017","article-title":"Vaccines against leishmaniasis","volume":"89","author":"Modabber","year":"1995","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2004.11.061_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0035-9203(72)90152-6","article-title":"Follow-up study of a vaccination programme against cutaneous leishmaniasis. I. Vaccination with a 5 year-old human strain of L. tropica from the Negev","volume":"66","author":"Gunders","year":"1972","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2004.11.061_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0035-9203(72)90153-8","article-title":"Follow-up study of a vaccination programme against cutaneous leishmaniasis. II. Vaccination with a recently isolated strain of L. tropica from Jericho","volume":"66","author":"Naggan","year":"1972","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"20","key":"10.1016\/j.vaccine.2004.11.061_bib41","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0264-410X(98)00075-9","article-title":"Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection","volume":"16","author":"Sjolander","year":"1998","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.061_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0001-706X(95)00079-T","article-title":"A highly sensitive and rapid procedure for direct PCR detection of Leishmania infantum within human peripheral blood mononuclear cells","volume":"59","author":"Ravel","year":"1995","journal-title":"Acta Trop"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2004.11.061_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-4017(01)00486-1","article-title":"An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine","volume":"100","author":"Gradoni","year":"2001","journal-title":"Vet Parasitol"},{"issue":"9","key":"10.1016\/j.vaccine.2004.11.061_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"Moreno","year":"2002","journal-title":"Trends Parasitol"},{"issue":"4845","key":"10.1016\/j.vaccine.2004.11.061_bib45","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.3344436","article-title":"Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity","volume":"239","author":"Titus","year":"1988","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2004.11.061_bib46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00002030-199402000-00024","article-title":"Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus","volume":"8","author":"Molina","year":"1994","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.vaccine.2004.11.061_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S0074-02761994000200001","article-title":"Visceral leishmaniasis in Teresina, State of Piaui, Brazil: preliminary observations on the detection and transmissibility of canine and sandfly infections","volume":"89","author":"Vexenat","year":"1994","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.vaccine.2004.11.061_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2004.11.061_bib49","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2004.11.061_bib50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3024.1995.tb00914.x","article-title":"Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites","volume":"17","author":"Deplazes","year":"1995","journal-title":"Parasite Immunol"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2004.11.061_bib51","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/S0264-410X(03)00046-X","article-title":"IgG1\/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis","volume":"21","author":"de Oliveira Mendes","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.061_bib52","first-page":"33","article-title":"Lessons from Leishmania: a model for investigations of CD4+ subset differentiation","volume":"1","author":"Reiner","year":"1992","journal-title":"Infect Agents Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.061_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1574-695X.1998.tb01129.x","article-title":"The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major","volume":"20","author":"Kemp","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2004.11.061_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2249.1995.tb03660.x","article-title":"Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections","volume":"100","author":"Gaafar","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2004.11.061_bib55","first-page":"1","article-title":"Regulator and effector functions of T-cell subsets in human Leishmania infections","volume":"68","author":"Kemp","year":"1997","journal-title":"APMIS"},{"issue":"12","key":"10.1016\/j.vaccine.2004.11.061_bib56","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/IAI.63.12.4894-4899.1995","article-title":"Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection","volume":"63","author":"Satoskar","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.11.061_bib57","first-page":"13","article-title":"Antigen processing and presentation: modelling with Leishmania","volume":"88","author":"Kaye","year":"1991","journal-title":"Behring Inst Mitt"},{"issue":"8","key":"10.1016\/j.vaccine.2004.11.061_bib58","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2004.11.061_bib59","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/IAI.67.11.5559-5566.1999","article-title":"Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells","volume":"67","author":"Mary","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.061_bib60","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1365-2249.1994.tb06044.x","article-title":"Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients","volume":"96","author":"Kurtzhals","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2004.11.061_bib61","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/icb.1993.64","article-title":"Interferon-gamma and interleukin-4 in human Leishmania donovani infections","volume":"71","author":"Kemp","year":"1993","journal-title":"Immunol Cell Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2004.11.061_bib62","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"Stager","year":"2000","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04009193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04009193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T01:36:26Z","timestamp":1682904986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04009193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":62,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0264410X04009193"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.11.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}